US EditionAIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal - AIM ImmunoTech (AMEX:AIM)
Summary by Benzinga
1 Articles
1 Articles
All
Left
Center
1
Right
AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal - AIM ImmunoTech (AMEX:AIM)
OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. ("AIM" or the "Company") (NYSE:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19, reported that on April 4, 2025, it received notification from NYSE Regulation of the NYSE American LLC (the "NYSE American" or the "Exchange") that it had suspended tradi…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
